One of the first companies to get into the business of destroying human embryos for stem cell research has decided to terminate or sell its embryonic stem cell research program in order to focus on more profitable cancer research.  This is just another indication that embryonic stem cell research is not just unethical, it’s also unprofitable.  Taxpayer dollars should not be spent on such research, especially since ethical forms of adult stem cell research and induced pluripotent stem cell research offer so much potential.

UPDATE: Check out our stem cell and adult stem cell pages for more information.

Exciting studies and human trials are taking place that show that ethical adult stem cell therapy can be useful in treating severe heart attack and Lou Gehrig's disease.

Dr. Gerard Nadal explains at LifeNews.

WSBT reports.

The Denver Post reports.

LifeNews reports.

David Klinghoffer explains, saying “[u]nlike embryonic stem cells, adult stem cells do have a record of healing. You wouldn’t know it from the media.”